Using Clodronate to Treat Bone Pain in a Child with Ewing Sarcoma
Author Information
Author(s): Siden Harold
Primary Institution: University of British Columbia
Hypothesis
Can subcutaneous clodronate effectively relieve bone pain in children with malignancy?
Conclusion
Subcutaneous clodronate effectively relieved bone pain in a child with Ewing sarcoma without side effects.
Supporting Evidence
- Clodronate was well tolerated and provided significant pain relief.
- The boy had previously unmanageable bone pain that improved with clodronate.
- Subcutaneous administration was chosen due to the child's preference and previous experiences.
Takeaway
A 9-year-old boy with cancer had bad bone pain, but after getting a special medicine called clodronate under his skin, he felt much better.
Methodology
The boy received 300 mg of clodronate subcutaneously every 4 weeks, monitored for side effects and pain relief.
Potential Biases
Potential bias in treatment choice due to lack of existing evidence for pediatric use of bisphosphonates.
Limitations
The study is based on a single case report, limiting generalizability.
Participant Demographics
A 9-year-old boy with Ewing Sarcoma.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website